Induction of sterilizing immunity against west nile virus (WNV), by immunization with WNV-like particles produced in insect cells

被引:49
作者
Qiao, M
Ashok, M
Bernard, KA
Palacios, G
Zhou, ZH
Lipkin, WI
Liang, TJ
机构
[1] NIDDKD, Liver Dis Sect, NIH, Bethesda, MD 20892 USA
[2] Columbia Univ, Mailman Sch Publ Hlth, Greene Infect Dis Lab, New York, NY USA
[3] Columbia Univ, Dept Epidemiol, New York, NY USA
[4] Columbia Univ, Dept Neurol, New York, NY USA
[5] Columbia Univ, Dept Pathol, New York, NY USA
[6] New York State Dept Hlth, Wadsworth Ctr, New York, NY USA
[7] Univ Texas, Med Sch Houston, Dept Pathol & Lab Med, Houston, TX USA
关键词
D O I
10.1086/425933
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
No specific vaccine for West Nile virus (WNV) is currently available for human use. In the present study, we describe the generation of WNV-like particles (WNV-LPs) in insect cells by use of recombinant baculoviruses expressing the WNV structural proteins prME or CprME. BALB/c mice immunized with purified WNV-LPs developed WNV-specific antibodies that had potent neutralizing activities. Mice immunized with prME-like particles (prME-LPs) showed no morbidity or mortality after challenge with WNV. Immunization with prME-LPs can induce sterilizing immunity without producing any evidence of viremia or viral RNA in the spleen or brain. These results suggest that WNV-LPs hold promise as a vaccine candidate for WNV infection.
引用
收藏
页码:2104 / 2108
页数:5
相关论文
共 20 条
[1]   Human immunoglobulin as a treatment for West Nile virus infection [J].
Agrawal, AG ;
Petersen, LR .
JOURNAL OF INFECTIOUS DISEASES, 2003, 188 (01) :1-4
[2]   Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating West Nile virus infection in mice [J].
Ben-Nathan, D ;
Lustig, S ;
Tam, G ;
Robinzon, S ;
Segal, S ;
Rager-Zisman, B .
JOURNAL OF INFECTIOUS DISEASES, 2003, 188 (01) :5-12
[3]   West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays [J].
Davis, BS ;
Chang, GJJ ;
Cropp, B ;
Roehrig, JT ;
Martin, DA ;
Mitchell, CJ ;
Bowen, R ;
Bunning, ML .
JOURNAL OF VIROLOGY, 2001, 75 (09) :4040-4047
[4]   Antibody prophylaxis and therapy against West Nile virus infection in wild-type and immunodeficient mice [J].
Engle, MJ ;
Diamond, MS .
JOURNAL OF VIROLOGY, 2003, 77 (24) :12941-12949
[5]   DNA vaccine coding for the full-length infectious Kunjin virus RNA protects mice against the New York strain of West Nile virus [J].
Hall, RA ;
Nisbet, DJ ;
Pham, KB ;
Pyke, AT ;
Smith, GA ;
Khomykh, AA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (18) :10460-10464
[6]   Immunization with hepatitis C virus-like particles induces humoral and cellular immune responses in nonhuman primates [J].
Jeong, SH ;
Qiao, M ;
Nascimbeni, M ;
Hu, ZY ;
Rehermann, B ;
Murthy, K ;
Liang, TJ .
JOURNAL OF VIROLOGY, 2004, 78 (13) :6995-7003
[7]   Virus detection protocols for West Nile virus in vertebrate and mosquito specimens [J].
Kauffman, EB ;
Jones, SA ;
Dupuis, AP ;
Ngo, KA ;
Bernard, KA ;
Kramer, LD .
JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (08) :3661-3667
[8]   Stable high-producer cell clone expressing virus-like particles of the Japanese encephalitis virus E protein for a second-generation subunit vaccine [J].
Kojima, A ;
Yasuda, A ;
Asanuma, H ;
Ishikawa, T ;
Takamizawa, A ;
Yasui, K ;
Kurata, T .
JOURNAL OF VIROLOGY, 2003, 77 (16) :8745-8755
[9]   Dengue type 2 virus subviral extracellular particles produced by a stably transfected mammalian cell line and their evaluation for a subunit vaccine [J].
Konishi, E ;
Fujii, A .
VACCINE, 2002, 20 (7-8) :1058-1067
[10]   A controlled trial of a human papillomavirus type 16 vaccine [J].
Koutsky, LA ;
Ault, KA ;
Wheeler, CM ;
Brown, DR ;
Barr, E ;
Alvarez, FB ;
Chiacchierini, LM ;
Jansen, KU .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (21) :1645-1651